MITOXANTRONE METABOLISM IN THE ISOLATED PERFUSED-RAT-LIVER

[1] PHASE-I CLINICAL-TRIAL OF MITOXANTRONE - A NEW ANTHRACENEDIONE ANTI-CANCER DRUG [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 5 (01) : 11 - 15

[2] ACTIVITY AND STABILITY OF MICROSOMAL MIXED FUNCTION OXIDASE AND NAD GLYCOHYDROLASE IN ISOLATED PERFUSED RAT-LIVER [J]. NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE, 1972, 273 (03): : 193 - &

[3] GOLDSMITH MA, 1981, P AM ASSOC CANC RES, V22, P389

[4] THE DOMINANT ROLE OF THE LIVER IN PLASMA PROTEIN SYNTHESIS - A DIRECT STUDY OF THE ISOLATED PERFUSED RAT LIVER WITH THE AID OF LYSINE-EPSILON C-14 [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1951, 94 (05) : 431 - 453

[5] NEIDHART J, 1981, P AM ASSOC CANC RES, V22, P363

[6] AN HPLC METHOD FOR THE QUANTITATIVE-DETERMINATION OF 1,4-DIHYDROXY-5,8 BIS [[2-[(2-HYDROXYETHYL)AMINO]ETHYL]AMINO]9,10-ANTHRACENEDIONE (DHAQ, LEDERLE LABS CL232315, NCS 301739) IN SERUM [J]. JOURNAL OF LIQUID CHROMATOGRAPHY, 1980, 3 (05): : 637 - 644

[7] CLINICAL ANALYSIS FOR THE ANTI-NEOPLASTIC AGENT 1,4-DIHYDROXY-5,8-BIS((2-[(2-HYDROXYETHYL)AMINO]ETHYL)-AMINO) 9,10-ANTHRACENEDIONE DIHYDROCHLORIDE (NSC 301739) IN PLASMA - APPLICATION OF TEMPERATURE CONTROL TO PROVIDE SELECTIVITY IN PAIRED-ION HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J]. JOURNAL OF CHROMATOGRAPHY, 1981, 222 (02): : 225 - 240

[8] VONHOFF DD, 1980, CANCER RES, V40, P1516

[1] PHASE-I CLINICAL-TRIAL OF MITOXANTRONE - A NEW ANTHRACENEDIONE ANTI-CANCER DRUG [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 5 (01) : 11 - 15

[2] ACTIVITY AND STABILITY OF MICROSOMAL MIXED FUNCTION OXIDASE AND NAD GLYCOHYDROLASE IN ISOLATED PERFUSED RAT-LIVER [J]. NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE, 1972, 273 (03): : 193 - &

[3] GOLDSMITH MA, 1981, P AM ASSOC CANC RES, V22, P389

[4] THE DOMINANT ROLE OF THE LIVER IN PLASMA PROTEIN SYNTHESIS - A DIRECT STUDY OF THE ISOLATED PERFUSED RAT LIVER WITH THE AID OF LYSINE-EPSILON C-14 [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1951, 94 (05) : 431 - 453

[5] NEIDHART J, 1981, P AM ASSOC CANC RES, V22, P363

[6] AN HPLC METHOD FOR THE QUANTITATIVE-DETERMINATION OF 1,4-DIHYDROXY-5,8 BIS [[2-[(2-HYDROXYETHYL)AMINO]ETHYL]AMINO]9,10-ANTHRACENEDIONE (DHAQ, LEDERLE LABS CL232315, NCS 301739) IN SERUM [J]. JOURNAL OF LIQUID CHROMATOGRAPHY, 1980, 3 (05): : 637 - 644

[7] CLINICAL ANALYSIS FOR THE ANTI-NEOPLASTIC AGENT 1,4-DIHYDROXY-5,8-BIS((2-[(2-HYDROXYETHYL)AMINO]ETHYL)-AMINO) 9,10-ANTHRACENEDIONE DIHYDROCHLORIDE (NSC 301739) IN PLASMA - APPLICATION OF TEMPERATURE CONTROL TO PROVIDE SELECTIVITY IN PAIRED-ION HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J]. JOURNAL OF CHROMATOGRAPHY, 1981, 222 (02): : 225 - 240

[8] VONHOFF DD, 1980, CANCER RES, V40, P1516